Clinical Trials

NCT06515860 | ACTIVE_NOT_RECRUITING
1000 participants

Neurofibromatosis Type 1 Tumor Early Detection Study

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-03
Start Date:
2024-08-07
Completion:
2030-07-31
Conditions
  • Neurofibromatosis Type 1
  • Neurofibromatosis 1
  • Plexiform Neurofibroma
  • Plexiform Neurofibromas
  • Malignant Peripheral Nerve Sheath Tumor
  • Malignant Peripheral Nerve Sheath Tumors
  • Atypical Neurofibroma
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT06466135 | RECRUITING | PHASE2
96 participants

Study of WAL0921 in Patients With Glomerular Kidney Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2024-07-02
Completion:
2027-03-31
Conditions
  • Diabetic Nephropathies
  • Primary Focal Segmental Glomerulosclerosis
  • Minimal Change Disease
  • Primary Immunoglobulin A Nephropathy
  • Primary Membranous Nephropathy
Interventions
  • DRUG
No Results Yet
NCT06465745 | RECRUITING | NA
450 participants

ATLAS (AltaValve) Pivotal Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2024-09-03
Completion:
2029-09-30
Conditions
  • Mitral Regurgitation
  • Mitral Insufficiency
  • Mitral Valve Incompetence
  • Mitral Valve Regurgitation
  • Mitral Incompetence
Interventions
  • DEVICE
No Results Yet
NCT06458907 | NOT_YET_RECRUITING | NA
780 participants

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2026-08-31
Completion:
2028-11-30
Conditions
  • Tricuspid Valve Disease
  • Heart Valve Diseases
  • Cardiovascular Diseases
  • Heart Failure
  • Tricuspid Valve Regurgitation
  • Tricuspid Valve Insufficiency
Interventions
  • DEVICE
  • DRUG
No Results Yet
NCT06374212 | COMPLETED | PHASE2
15 participants

Anifrolumab for Hidradenitis Suppurativa

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2024-06-21
Completion:
2026-01-22
Conditions
  • Hidradenitis Suppurativa
  • Acne Inversa
  • Hidradenitis
Interventions
  • DRUG
No Results Yet
NCT06305754 | ACTIVE_NOT_RECRUITING | PHASE3
551 participants

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-03
Start Date:
2024-06-11
Completion:
2028-08-17
Conditions
  • Non-small Cell Lung Cancer (NSCLC)
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page